Vaccinations at Tanzania Clinical Site Credit: Tom Wilkinson University of Oxford The Ghana Food and Drugs Authority (FDA) has granted full national licensure for the R21/Matrix-MTM malaria vaccine, developed by the University of Oxford. The clearance of R21/Matrix-MTM, manufactured leveraging an adjuvant technology from Novavax, and scaled up by the…Read More
FDA Approves Oxfords R21MatrixMTM Malaria Vaccine
